The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 26 11 2020
accepted: 25 01 2021
pubmed: 26 6 2021
medline: 3 2 2022
entrez: 25 6 2021
Statut: ppublish

Résumé

Total pancreatectomy for severe pain in end-stage chronic pancreatitis may be the only option, but with vascular involvement, this is usually too high risk and/or technically not feasible. The purpose of the study was to present the clinical outcomes of a novel procedure in severe chronic pancreatitis complicated by uncontrollable pain and vascular involvement. We describe an in situ near-total pancreatectomy that avoids peripancreatic vascular dissection (Livocado procedure) and report on surgical and clinical outcomes. The Livocado procedure was carried out on 18 (3.9%) of 465 patients undergoing surgery for chronic pancreatitis. There were 13 men and 5 women with a median (IQR) age of 48.5 (42.4-57) years and weight of 60.7 (58.0-75.0) kg. All had severe pain and vascular involvement; 17 had pancreatic parenchymal calcification; the median (IQR) oral morphine equivalent dose requirement was 86 (33-195) mg/day. The median (IQR) maximal pain scores were 9 (9-10); the average pain score was 6 (IQR 4-7). There was no peri-operative or 90-day mortality. At a median (IQR) follow-up of 32.5 (21-45.75) months, both maximal and average pain scores were significantly improved post-operatively, and at 12 months, two-thirds of patients were completely pain free. Six (33%) patients had employment pre-operatively versus 13 (72%) post-operatively (p = 0.01). The Livocado procedure was safe and carried out successfully in patients with chronic pancreatitis with vascular involvement where other procedures would be contraindicated. Perioperative outcomes, post-operative pain scores, and employment rehabilitation were comparable with other procedures carried out in patients without vascular involvement.

Identifiants

pubmed: 34169341
doi: 10.1007/s00423-021-02107-x
pii: 10.1007/s00423-021-02107-x
pmc: PMC8803758
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2657-2668

Informations de copyright

© 2021. The Author(s).

Références

Ann Surg. 2012 Apr;255(4):763-70
pubmed: 22418009
Chirurg. 1980 May;51(5):303-7
pubmed: 7408575
Surgery. 2016 Jul;160(1):127-135
pubmed: 27106794
Ann Surg. 1989 Mar;209(3):273-8
pubmed: 2923514
Gastroenterology. 1984 May;86(5 Pt 1):820-8
pubmed: 6706066
Ann Surg. 1998 Feb;227(2):213-9
pubmed: 9488519
Surgery. 2019 May;165(5):938-945
pubmed: 30658850
Pancreatology. 2020 Jul;20(5):910-918
pubmed: 32624419
Surgery. 2004 Apr;135(4):411-8
pubmed: 15041965
Pancreatology. 2014 Nov-Dec;14(6):490-6
pubmed: 25224249
Lancet. 2017 Sep 9;390(10099):1027-1037
pubmed: 28901935
Gastroenterology. 2001 Feb;120(3):682-707
pubmed: 11179244
Pancreatology. 2016 Mar-Apr;16(2):218-24
pubmed: 26924663
Br J Surg. 2004 Aug;91(8):1020-6
pubmed: 15286965
Lancet. 2016 May 7;387(10031):1957-66
pubmed: 26948434
Nat Rev Dis Primers. 2017 Sep 07;3:17060
pubmed: 28880010
Scand J Surg. 2020 Sep;109(3):177-186
pubmed: 31232190
Arch Intern Med. 2009 Jun 8;169(11):1035-45
pubmed: 19506173
Pancreas. 1987;2(6):701-7
pubmed: 3438308
Gastroenterology. 2013 Jun;144(6):1252-61
pubmed: 23622135
Pancreatology. 2018 Oct;18(7):764-773
pubmed: 30177434
Pancreatology. 2020 Mar;20(2):149-157
pubmed: 31870802
Gastroenterol Res Pract. 2015;2015:245460
pubmed: 26451142
Pancreatology. 2017 Sep - Oct;17(5):720-731
pubmed: 28734722
Ann Surg. 1999 Oct;230(4):512-9; discussion 519-23
pubmed: 10522721
Br J Surg. 2003 Nov;90(11):1401-8
pubmed: 14598422
Am J Gastroenterol. 2011 Dec;106(12):2192-9
pubmed: 21946280
Br J Surg. 1997 May;84(5):624-9
pubmed: 9171747
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
HPB (Oxford). 2011 Dec;13(12):839-45
pubmed: 22081918
Pancreatology. 2020 Jun;20(4):762-771
pubmed: 32327370
JAMA. 2020 Jan 21;323(3):237-247
pubmed: 31961419
Langenbecks Arch Surg. 2019 Nov;404(7):831-840
pubmed: 31748872
United European Gastroenterol J. 2014 Oct;2(5):345-54
pubmed: 25360312
Pancreatology. 2020 Jun;20(4):586-593
pubmed: 32414657
Gastroenterology. 1999 May;116(5):1132-40
pubmed: 10220505
Dig Surg. 2001;18(1):21-5
pubmed: 11244255
Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):838-44
pubmed: 16885867
Surgery. 2011 Mar;149(3):321-8
pubmed: 20684965
Ann Surg. 2021 Apr 1;273(4):800-805
pubmed: 31348039
Gastroenterology. 1994 Nov;107(5):1481-7
pubmed: 7926511
Pancreatology. 2020 Jun;20(4):579-585
pubmed: 32376198

Auteurs

Ryan D Baron (RD)

Department of Pancreato-Biliary Surgery, The Royal Liverpool University Hospital, Liverpool, UK.

Andrea R G Sheel (ARG)

Department of Pancreato-Biliary Surgery, The Royal Liverpool University Hospital, Liverpool, UK.
Department of Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.

Ammad Farooq (A)

Department of Radiology, The Royal Liverpool University Hospital, Liverpool, UK.

Jörg Kleeff (J)

Department of Visceral, Vascular and Endocrine Surgery, Martin, Halle (Saale), Germany.

Pietro Contin (P)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Baden-Württemberg, Germany.

Christopher M Halloran (CM)

Department of Pancreato-Biliary Surgery, The Royal Liverpool University Hospital, Liverpool, UK.
Department of Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.

John P Neoptolemos (JP)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Baden-Württemberg, Germany. john.neoptolemos@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH